Monomethyl auristatin E is a complex peptide-based compound used as a pharmaceutical intermediate in the manufacturing of antibody-drug conjugates. Its structure features multiple amide groups, an aromatic ring, and several chiral centers, contributing to its role as a key building block in targeted therapeutic development.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 474645-27-7
L-Valinamide, N,N-dimethyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydro xy-1-methyl-
active pharmaceutical ingredient
MMAF
pharmaceutical intermediate
Mc-MMAE
antibody-drug conjugate payload
MC-Gly-Gly-Phe-Gly
pharmaceutical intermediate for antibody-drug conjugate
N-Acetyl calicheamicin
pharmaceutical intermediate for antibody-drug conjugate
Hydronopol
Pharmaceutical intermediate for pivonium bromide
Tert-Butyl 3,4-dihydroxypiperidine-1-carboxylate
Pharmaceutical intermediate
(5-Bromo-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid
Pharmaceutical intermediate for synthesis
(2S)-N-[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide
DASWEROEPLKSEI-UIJRFTGLSA-N
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC